Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenerative Medical Technology (RMTG) Debt Ratio (2017 - 2025)

Historic Debt Ratio for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to 3.75.

  • Regenerative Medical Technology's Debt Ratio rose 15512064.27% to 3.75 in Q3 2025 from the same period last year, while for Sep 2025 it was 3.75, marking a year-over-year increase of 15512064.27%. This contributed to the annual value of 0.52 for FY2024, which is 1508552.26% up from last year.
  • Latest data reveals that Regenerative Medical Technology reported Debt Ratio of 3.75 as of Q3 2025, which was up 15512064.27% from 0.62 recorded in Q2 2025.
  • Over the past 5 years, Regenerative Medical Technology's Debt Ratio peaked at 3.75 during Q3 2025, and registered a low of 0.0 during Q1 2022.
  • Over the past 5 years, Regenerative Medical Technology's median Debt Ratio value was 0.09 (recorded in 2021), while the average stood at 0.62.
  • Per our database at Business Quant, Regenerative Medical Technology's Debt Ratio plummeted by 9993.3% in 2021 and then soared by 15512064.27% in 2025.
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Debt Ratio stood at 1.27 in 2021, then crashed by 99.92% to 0.0 in 2022, then soared by 257.87% to 0.0 in 2023, then surged by 15085.52% to 0.52 in 2024, then surged by 614.91% to 3.75 in 2025.
  • Its Debt Ratio was 3.75 in Q3 2025, compared to 0.62 in Q2 2025 and 0.5 in Q1 2025.